Jose ́A. Melero

Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

María Florencia Delgado, Silvina Coviello, Ana C. Monsalvo et al. · Nature Medicine · 2008 · 496 citations · Full text

Vaccination, Respiratory Virus Immunity, Respiratory Diseases +9

Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection

Laurent Detalle, Thomas Stöhr, Concepción Palomo et al. · Antimicrobial Agents and Chemotherapy · 2015 · 289 citations · Full text

Major changes in the G protein of human respiratory syncytial virus isolates introduced by a duplication of 60 nucleotides

Alfonsina Trento, Mónica Galiano, Cristina Videla et al. · Journal of General Virology · 2003 · 283 citations

Viral Replication, Major Changes, Genetics +16

Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention

Margarita Magro, Vicente Más, Keith J. Chappell et al. · Proceedings of the National Academy of Sciences · 2012 · 265 citations · Full text

Respiratory Virus Immunity, Immunology, Viral Pathogenesis +19

Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion

Luis González-Reyes, M. Begoña Ruiz-Argüello, Blanca García‐Barreno et al. · Proceedings of the National Academy of Sciences · 2001 · 237 citations · Full text